SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is surging after a preliminary business update revealed record-shattering new orders and a significant beat on gross margin guidance. Community sentiment has shifted aggressively toward a potential short squeeze, as investors focus on the company's massive order backlog and stronger-than-expected profitability in the AI server sector.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet is trending as investors react to reports of delays in the rollout of its flagship Gemini 3.5 Pro AI model, sparking concerns over the company's competitive position against OpenAI and Anthropic. The community is sharply divided, with many viewing the dip as a prime accumulation opportunity for a long-term AI infrastructure play, while others worry that high CAPEX spending without immediate product breakthroughs could pressure the stock.

Alphabet Inc - Ordinary Shares - Class C

Alphabet is currently a major focal point for investors as the company's upcoming earnings report is seen as a pivotal catalyst for the broader AI sector's trajectory. Market participants are heavily scrutinizing the company's AI-related capital expenditure guidance and cloud revenue growth, as these figures are expected to set the tone for the sustainability of the ongoing AI infrastructure buildout.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the following segments: Materials and Magnetics. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP Materials is trending as investors react to China adding the company to its export control list, a development that highlights its strategic importance to the U.S. defense and technology supply chain. The community is actively discussing the stock's role in domestic production, while technical traders are monitoring key support levels and insider activity to gauge the next potential reversal.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is seeing heightened trading volume and social activity as the community debates its long-term potential versus concerns over market performance and the ecosystem's tokenomics. Investors remain sharply divided between those viewing the current price as an accumulation opportunity and critics who argue the asset is failing to gain meaningful traction.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

TQQQ is trending as investors weigh potential market volatility stemming from escalating U.S.-Iran tensions and geopolitical uncertainty against optimistic outlooks for semiconductor earnings and AI-driven growth. Community discussion is heavily focused on whether current market pullbacks represent a buying opportunity for a rebound or if broader economic risks, such as inflation and energy supply concerns, could trigger a more significant downturn.

Polkadot is a platform that allows diverse blockchains to transfer messages, including value, in a trust-free fashion; sharing their unique features while pooling their security. In brief, Polkadot is a scalable heterogeneous multi-chain technology.  Polkadot is heterogeneous because it is entirely flexible and makes no assumption about the nature or structure of the chains in the network. Even non-blockchain systems or data structures can become parachains if they fulfill a set of criteria.  Polkadot may be considered equivalent to a set of independent chains (e.g. a set containing Ethereum, Ethereum Classic, Namecoin and Bitcoin) except with important additions: pooled security and trust-free interchain transactability.  Many of the native parachains of Polkadot will be written using a Polkadot Runtime Environment SDK (e.g. Parity Technologies' Substrate).

Polkadot

Polkadot is currently a polarizing subject in the community as investors debate its long-term viability amid a prolonged downtrend and questions regarding its actual utility. While some market participants are actively accumulating the token at lower prices in anticipation of potential upgrades and a future altcoin recovery, many others are expressing strong skepticism, citing consistent price depreciation and a lack of institutional demand compared to other major projects.

ProShares Trust - ProShares UltraPro Short QQQ -3x Shares

ProShares UltraPro Short QQQ

The ProShares UltraPro Short QQQ (SQQQ) is trending as traders aggressively hedge against a potential tech sector correction amid heightened geopolitical tensions and persistent inflation concerns. The community is actively debating the sustainability of the AI-driven market rally, with many viewing leveraged inverse ETFs as essential tools for navigating near-term volatility and structural market risks.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell Technologies is trending as investors monitor its resilience and infrastructure leadership amid broader sector volatility, with the community actively debating whether the stock's recent price action signals a breakout or a potential correction driven by AI demand cycles. Traders are closely analyzing order flow and comparative performance against peers like Super Micro Computer and HPE, while weighing the impact of institutional activity and macro-sensitive catalysts on the company's enterprise AI server growth story.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently in the spotlight as investors react to a significant expansion of the National Security Space Launch contract ceiling, which now reaches $17 billion. Community members are intensely debating whether this contract win and ongoing growth in government defense work will serve as the necessary catalyst to stabilize the stock's recent volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

GALT Jumps 11% on FDA Alignment for Belapectin Phase III Path in MASH

Galectin stock rises following FDA alignment on key elements of belapectin's phase III MASH cirrhosis program, clarifying a potential path toward full approval.

GALT Stock Surges 22% — On Track For Best Day In Over A Year After FDA Clears Path For Late-Stage Belapectin Trial

Equity

Galectin plans to submit the final trial protocol to the FDA in the third quarter of 2026.


Galectin Therapeutics (GALT) Upgraded to Buy: What Does It Mean for the Stock?

Galectin Therapeutics (GALT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

FY2026 Earnings Estimate for GALT Issued By HC Wainwright

Galectin Therapeutics Inc. (NASDAQ:GALT - Free Report) - Research analysts at HC Wainwright lifted their FY2026 earnings estimates for shares of Galectin Therapeutics in a note issued to investors on...

What is HC Wainwright's Estimate for GALT Q1 Earnings?

Galectin Therapeutics Inc. (NASDAQ:GALT - Free Report) - Equities researchers at HC Wainwright issued their Q1 2026 EPS estimates for shares of Galectin Therapeutics in a note issued to investors on...

Galectin Therapeutics (NASDAQ:GALT) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Galectin Therapeutics (NASDAQ:GALT - Get Free Report) announced its quarterly earnings results on Tuesday. The company reported ($0.08) EPS for the quarter, beating analysts' consensus estimates of ($0.10) by $0.02...

Galectin Therapeutics Inc. (NASDAQ:GALT) Short Interest Up 27.0% in March

Galectin Therapeutics Inc. (NASDAQ:GALT - Get Free Report) saw a large increase in short interest in the month of March. As of March 13th, there was short interest totaling 6,567,660 shares, an increase of 27.0% from the February 26th total of 5,169,383 shares. Currently, 21.5% of the company's...

Galectin Therapeutics (GALT) Projected to Post Earnings on Monday

Galectin Therapeutics (NASDAQ:GALT) will be releasing its Q4 2025 earnings before the market opens on Monday, March 30. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-3-30-galectin-therapeutics-inc-stock...

Galectin Therapeutics Highlights Belapectin Data in MASH Cirrhosis KOL Event, Eyes Next Steps

Galectin Therapeutics (NASDAQ:GALT) hosted a virtual key opinion leader (KOL) event to discuss belapectin as a potential treatment for patients with metabolic dysfunction-associated steatohepatitis...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galectin Therapeutics Inc. - GALT

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galectin Therapeutics Inc. - GALT INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$3.85
Prev Close	$4.00
Open	$4.01
Dividend Yield	0.00%
50-Day Moving Average	$3.23
Beta	0.58
Avg. Volume	1.01M
PE Ratio	-9.38

52-Week High	$7.13
52-Week Low	$2.03
Market Capitalization	$263.43M
EPS (Annual)	-$0.4847
Price to Book	-1.91
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

GALTGalectin Therapeutics Inc

Latest GALT News